+91 9891296838 / 9811747774
Denopsy is used for the reduction of frequency of relapsing forms of multiple sclerosis (a disease that affects the brain and spinal cord) in adult patients. It also helps to slow down the worsening of disability in such patients.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of Denopsy (Teriflunomide) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the medicine and its cost price in India.
The order for Denopsy (Teriflunomide) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Teriflunomide is used to treat multiple sclerosis-MS. It is not a cure for MS but is thought to work by decreasing certain immune system cells (lymphocytes) which can attack the nerves in your brain and spinal cord. This helps decrease the number of flare-ups (relapses) and may help slow down physical problems caused by MS.
AUBAGIO® (teriflunomide) tablets, for oral use Initial U.S. Approval: 2012
Generic Name: Teriflunomide
14 mg and 7 mg tablets.
60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Denopsy (Teriflunomide) on prescription and Import License in Patient's Name only.
For overseas patients, Denopsy (Teriflunomide) can be made available in Send your enquiry to find Denopsy (Teriflunomide) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
Natco launches first generic of Teriflunomide in India For More Details
Alembic Pharmaceuticals receives USFDA approval for Teriflunomide Tablets For More Details